Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral tranexamic acid in female patients with melasma (metabolomic mechanism study)
ChiCTR2200061648Phase 4Not yet recruiting
- Sponsor
- Institute of Dermatology, Chinese Academy of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid in melasma (2 arms), sponsored by Institute of Dermatology, Chinese Academy of Medical Sciences. Primary endpoints: Change of mMASI (Modified Melasma Area and Severity Index) and Metabolomics testing. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on ChiCTR2200061648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061648.